drugset
drugset / Trial / NCT00048854

Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder

NCT00048854 ↗

Phase 1/2 Completed 66 enrolled Yale University National Institute of Mental Health (NIMH) · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will determine whether characteristics of women with Premenstrual Syndrome influence response to treatment with serotonin reuptake inhibitors and whether SRIs can alleviate premenstrual symptoms.

Timeline

Start
2001-09
Primary completion
2007-06
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 50 mg —

Indications

premenstrual tension